ASIT Biotech S.A
ASIT.BR
| Exchange: | BR |
| Currency | Euro |
| ISIN: | BE0974289218 |
| LEI: | 549300S8FE7T7B105H72 |
| Primary Ticker: | ASIT.BR |
| Fiscal Year End: | December |
| International Domestic: | International |
| Sector: | Healthcare |
| Industry: | Biotechnology |
| Gic Sector: | Health Care |
| Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| Gic Industry: | Biotechnology |
| Gic Sub Industry: | Biotechnology |
| Description: | ASIT Biotech S.A., a biopharmaceutical company, focuses on the research, development, and commercialization of immunotherapy products for the treatment of allergies in Belgium and internationally. Its lead product is gp-ASIT+, which is in the Phase III trial for the treatment of grass pollen rhinitis. The company is also developing hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy. ASIT Biotech S.A. was incorporated in 1997 and is based in Liege, Belgium. |
| Address: | 7 Rue des Chasseurs Ardennais, Liege, Belgium, 4031 |
| Website: | https://www.asitbiotech.com |
| Updated On: | 2022-03-03 |
Highlights
| Market Capitalization: | 5013405 |
| Market Capitalization Mln: | 5.01 |
| EBITDA: | 64339 |
| Wall Street Target Price: | 3.8 |
| Book Value: | 0.07 |
| Earnings Share: | -0.00 |
| Most Recent Quarter: | 2021-06-30 |
| Profit Margin: | -0.42 |
| Operating Margin TTM: | 0.26 |
| Return On Assets TTM: | 0.01 |
| Revenue TTM: | 342944 |
| Revenue Per Share TTM: | 0.01 |
| Quarterly Revenue Growth YOY: | -0.98 |
| Gross Profit TTM: | 358944 |
| Diluted Eps TTM: | -0.00 |
Valuation
| Price Sales TTM: | 14.61 |
| Price Book MRQ: | 3.62 |
| Enterprise Value: | 7459370 |
| Enterprise Value Ebitda: | 44.66 |
Shares
| Shares Outstanding: | 21892600 |
| Shares Float: | 17857131 |
| Percent Insiders: | 24.59 |
| Percent Institutions: | 5.58 |
Technicals
| Beta: | 1.33 |
| 50 Day MA: | 0.22 |
| 200 Day MA: | 0.28 |
Earnings
| Date: | 2019-12-31 |
| Period: | +1y |
| Revenue Estimate Number Of Analysts: | 5.00 |
| Eps Trend7days Ago: | -0.84 |
| Eps Trend30days Ago: | -0.84 |
| Eps Trend60days Ago: | -0.84 |
| Eps Trend90days Ago: | -0.84 |
| Eps Revisions Up Last7days: | 1.00 |
| Eps Revisions Up Last30days: | 1.00 |
| Date: | 2019-06-30 |
| Period: | +1q |
| Revenue Estimate Number Of Analysts: | 5.00 |
| Date: | 2019-03-31 |
| Revenue Estimate Number Of Analysts: | 5.00 |
| Date: | 2018-12-31 |
| Revenue Estimate Number Of Analysts: | 5.00 |
| Eps Trend7days Ago: | -0.75 |
| Eps Trend30days Ago: | -0.75 |
| Eps Trend60days Ago: | -0.75 |
| Eps Trend90days Ago: | -0.75 |
| Eps Revisions Up Last7days: | 1.00 |
| Eps Revisions Up Last30days: | 1.00 |